Last reviewed · How we verify
Metastatic prostate cancer
Approved treatments
- Nubeqa · Bayer
Darolutamide inhibits androgen receptor activity, reducing prostate cancer cell growth and tumor size.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Metastatic prostate cancer patent landscape — cliff calendar, originator estates, attackable patents
- Metastatic prostate cancer treatment landscape brief
- Metastatic prostate cancer treatment updates RSS
Frequently asked questions about Metastatic prostate cancer
What drugs treat Metastatic prostate cancer?
Tracked treatments include Nubeqa.
What is the treatment for Metastatic prostate cancer?
Standard treatment for Metastatic prostate cancer includes Nubeqa. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Metastatic prostate cancer patent cliff · Metastatic prostate cancer CI report
- Treatment: Nubeqa · Bayer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing